Method development (R&D)

Enhance method development with state-of-the-art techniques and processes.

Why is method development important?

Analytical method development is the strategic selection and optimization of analytical techniques tailored to quantify a designated attribute of a drug substance or product. This multifaceted exercise employs a systematic framework for assessing and choosing methodologies that exhibit:

  • Sensitivity: Designed with a low limit of detection to measure small amounts of analyte
  • Specificity: Highly specific for the analyte of interest, distinguishing it from other present materials
  • Accuracy:  Yields results that are close to the true value
  • Precision: Reproducible method that leads to consistent results
  • Robustness: Resilient to small variations leading to method consistency
  • Compliance with regulations: Meets the requirements of regulatory bodies such as the USFDA or EMA

In addition to these criteria, the method should also be efficient and cost-effective.

Understanding our method development capabilities

We employ state-of-the-art techniques throughout our method development processes to ensure precise measurement of various critical quality attributes (CQA).

These methods encompass various types of analyses including:

  • Product variants
  • Content
  • Excipient
  • Process related impurities

For assessing defined attributes we utilize the following methods:

  • Identity

    • Isoform patterns by cIEF, CE-IEF

    • High-performance liquid chromatography (HPLC)
  •  Structure
    • Primary structure
      • Intact or reduced mass analysis
      • Peptide mapping
    • Higher-order structure
      • Circular dichroism and
      • Intrinsic flourescence assays
      • Differential scanning calorimetry (DSC)
      • Disulphide bond analysis
  • Quantity

    • Total protein content

    • UV absorbance

  • Impurity

    • HCP, HCD by RT-PCR

    • Aggregates by SE-HPLC or CE

    • Cell substrate impurities

    • Enzyme-linked immunosorbent assay (ELISA)

    • Reverse transcription-polymerase chain reaction (RT-PCR)

    • Charge variants by cIEF
  • Biological Activity

    • Cell based assay

    • Binding assay (Octet® surface plasmon resonance (SPR), and ELISA assays)

  • Microbial testing

    • Microbiological tests (sterility etc.)

    • Endotoxin

    • Sterility testing

      • Membrane filtration

      • Direct Inoculation

Why partner with Enzene?

We are a global Continuously Innovative Development and Manufacturing Organization (CIDMO), dedicated to changing the paradigm by which affordable biologic and biosimilar medicines are brought to market. Since Enzene’s inception, our innovative agility has enabled us to continually introduce transformative processes in biologics manufacturing that significantly increase product yields of complex biologics and monoclonal antibodies (mAbs) while reducing the manufacturing footprint and the cost of production.

Game-changing innovation is only the beginning, though. We are Enzene, and that means that our values of innovation, entrepreneurship, respect, candor, excellence, and integrity underscore everything we do from project management and communications to teamwork and ideation. To us, true partnership is about driving biotech innovation while doing so in a way that develops long-lasting trusted partnerships.

Learn more about us

The future begins now

Your biologic deserves the most technologically advanced manufacturing process in the industry. And you deserve a new way to think about strategic partnership. Today is just the beginning.